Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin. 1988

F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
Department of Medicine, Roger Williams General Hospital, Providence, RI 02908.

Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin (dCF) were evaluated in 15 patients with advanced malignancies. Toxicity was less severe with a low dose (4 mg/m2) of dCF, but this dose still resulted in suppression of cellular adenosine deaminase activity, skin test reactivity, and lymphocyte responses to mitogens. Improvement in cutaneous T cell lymphoma plaques was seen after dCF. Further investigations of antitumor efficacy with the use of this low dosage schedule should continue in patients with hematologic neoplasms, and additional preliminary studies of the combination of an adenosine deaminase inhibitor with an adenosine analog should also be considered.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D003070 Coformycin A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine

Related Publications

F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
December 1996, Hematology and cell therapy,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
October 1973, Bollettino chimico farmaceutico,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
June 1981, Cancer research,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
August 1979, Cancer research,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
July 1981, Blood,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
January 1980, Cancer chemotherapy and pharmacology,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
October 1980, Biochemical pharmacology,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
April 1968, Archives internationales de pharmacodynamie et de therapie,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
September 1989, Bone marrow transplantation,
F J Cummings, and G W Crabtree, and M C Wiemann, and E N Spremulli, and R E Parks, and P Calabresi
January 1986, Zeitschrift fur arztliche Fortbildung,
Copied contents to your clipboard!